Like in ALL cell lines, BCL-XL or MCL-1 inhibition increased the sensitivity to venetoclax induced cell death showing synergistic activity in all xenografts (Fig. 7A, B; Supplementary Fig. 12). The gene discussed is BCL2L1; the disease is acute lymphoblastic leukemia.